Feng Ming Liu

Chief Executive Officer at Changzhou Biowin Pharmaceutical Co., Ltd.

64 year

Health Technology

Process Industries

Consumer Services

Profile

Feng Ming Liu is currently the Chairman & General Manager at Changzhou Biowin Pharmaceutical Co., Ltd.
Previously, he worked as the Chief Executive Officer & Chief Scientist at Shineco, Inc. Liu holds a doctorate degree from Peking Union Medical College.

Feng Ming Liu active positions

Companies	Position	Start
Changzhou Biowin Pharmaceutical Co., Ltd. Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China.	Chief Executive Officer	01/01/2012

All active positions of Feng Ming Liu

Former positions of Feng Ming Liu

Companies	Position	End
SHINECO, INC.	Chief Executive Officer	-

See the detail of Feng Ming Liu's experience

Training of Feng Ming Liu

Peking Union Medical College

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Feng Ming Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHINECO, INC.	Process Industries

Private companies	1
Changzhou Biowin Pharmaceutical Co., Ltd. Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China.	Health Technology